Brief: Nautilus Biotechnology Reports Quarterly Loss Per Share $0.12
Aug 2 (Reuters) - Nautilus Biotechnology Inc NAUT.O :
* NAUTILUS BIOTECHNOLOGY REPORTS SECOND QUARTER 2022
FINANCIAL
RESULTS
* QTRLY LOSS PER SHARE $0.12
* CASH, CASH EQUIVALENTS, AND INVESTMENTS WERE $334.9
MILLION AS
OF JUNE 30, 2022
* Q3 EARNINGS PER SHARE VIEW $-0.19 -- REFINITIV IBES DATA
* ANTICIPATE OUR CASH RUNWAY EXTENDING WELL INTO 2025
Source text for Eikon: ID:nGNX8xMlsH
Further company coverage: NAUT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nautilus Biotechnology
See all newsNautilus Biotechnology, Inc. expected to post a loss of 14 cents a share - Earnings Preview
Brief: Nautilus Biotechnology May Offer Up To $300 Million Of Securities - SEC Filing
Nautilus Biotechnology Inc reports results for the quarter ended June 30 - Earnings Summary
Nautilus Biotechnology posts first revenue, Q2 net loss narrows
Brief: Nautilus Biotechnology Q2 EPS USD -0.11